RecruitingPhase 3NCT05367206

Neoadjuvant Chemotherapy Followed by Chemoradiation Versus Chemoradiation for Stage IIIC Cervical Cancer Patients: A Randomized Phase III Trial

Department of Radiation, Sun Yat-sen University


Sponsor

Sun Yat-sen University

Enrollment

280 participants

Start Date

Mar 14, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Evaluate the efficacy and safety of neoadjuvant chemotherapy (NAC) with albumin-bound paclitaxel and carboplatin followed by chemoradiation therapy (CRT) for stage IIIC cervical cancer patients with carcinoma \>4 cm in greatest dimension and/or lymph node \>2cm in short axis.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This randomized trial is comparing two treatment approaches for stage IIIC cervical cancer: chemotherapy given before chemoradiation (combined chemo + radiation) versus chemoradiation alone. Researchers want to find out if starting with chemotherapy first improves survival. **You may be eligible if...** - You are 18–70 years old - You have been newly diagnosed with stage IIIC cervical cancer (confirmed by biopsy as squamous cell, adenocarcinoma, or adenosquamous type) - Your tumor is larger than 4 cm or you have lymph node involvement greater than 2 cm - You are in reasonably good health (ECOG 0–2) - Your organ function is adequate **You may NOT be eligible if...** - You have previously been treated for cervical cancer - You have another type of cancer - You are not at the initial diagnosis stage Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAlbumin-Bound Paclitaxel

260mg/m2 q3w \*2 circles

DRUGCarboplatin

AUC 5-6 q3w \* 2 circles


Locations(1)

Sun Yat-sen University Cancer Center

Guangzhou, Guangdone, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05367206


Related Trials